Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0 - Yahoo Finance

NPHC Stock  USD 0.0001  0.00  0.00%   
About 55% of Nutra Pharma's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Nutra Pharma Corp pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Nutra Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Nutra Pharma Corp stock news signals to limit their universe of possible portfolio assets.
  
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0 Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Nutra Pharma Fundamental Analysis

We analyze Nutra Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nutra Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nutra Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Peers

Trending Equities

AA  1.49   
0%
46.0%
UPS  1.03   
0%
32.0%
CVX  0.74   
0%
23.0%
AAPL  0.18   
0%
5.0%
BBY  0.13   
0%
4.0%
T  0.08   
2.0%
0%
IBM  0.51   
15.0%
0%
MET  0.63   
19.0%
0%
HD  0.95   
29.0%
0%
CVS  1.40   
43.0%
0%
AAL  1.44   
45.0%
0%
TGT  1.44   
45.0%
0%
WFC  2.30   
72.0%
0%
S  2.73   
85.0%
0%
C  2.94   
92.0%
0%
INTC  3.19   
100.0%
0%

Complementary Tools for Nutra Pink Sheet analysis

When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
News Freq…Investor S…